In 2014 our CEO and founder, José Mejía Oneto, left his residency in orthopedic surgery. After spending his days in the operating room, dramatically transforming the human body with incredible specificity, he wanted to create a better way to get drugs precisely to the place where they were needed.
His PhD training in organic chemistry presented a solution: click chemistry!
Catalyzed by a chance meeting with future Nobel Prize laureate Dr. Carolyn Bertozzi, José was accepted into the accelerator program, Y Combinator, to advance the development of his idea.
Fast forward to today, Shasqi has developed a clinically validated technology which uses click chemistry to activate cancer drugs at the tumor.